EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Cécile DURAND •  doctorante


 

2022

Pas de publications

2021

  • Beaumont A, Durand C, Ledrans M, Schwoebel V, Noel H, Le Strat Y, Diulius D, Colombain L, Médus M, Gueudet P, Mouly D, Aumaître H. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study. BMJ Open. 2021 Nov 23;11(11):e053201. doi: 10.1136/bmjopen-2021-053201.
     
  • Spaccaferri G, Calba C, Vilain P, Garras L, Durand C, Pilorget C, Atiki N, Bernillon P, Bosc L, Fougère E, Hanon JB, Henry V, Huchet-Kervella C, Martel M, Pontiès V, Mouly D, Rolland du Roscoat E, Le Vu S, Desenclos JC, Laporte A; Regional MONIC group, Rolland P. COVID-19 hotspots through clusters analysis in France (may-October 2020): where should we track the virus to mitigate the spread? BMC Public Health. 2021 Oct 11;21(1):1834. doi: 10.1186/s12889-021-11857-8.

2020

  • Durand C, Catelinois O, Bord A, Richard JB, Bidondo ML, Ménard C, Cousson-Gélie F, Mahé E, Mouly D, Delpierre D. Effect of an Appearance-Based vs. a Health-Based Sun-Protective Intervention on French Summer Tourists' Behaviors in a Cluster Randomized Crossover Trial: The PRISME Protocol.   Front. Public Health, 05 November 2020. doi:https://doi.org/10.3389/fpubh.2020.569857.

2019

Pas de publications